Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T02:12:29.221Z Has data issue: false hasContentIssue false

An Investigation into the Effects of Azacyclonal on the Hallucinations of Chronic Schizophrenic Patients

Published online by Cambridge University Press:  08 February 2018

Extract

Frenquel, α-(4-piperidyl) benzhydrol hydrochloride, generically known as Azacyclonal hydrochloride was introduced commercially into this country in the early part of 1957 although it had already been available in the United States of America for several months previously. Sargant (1956) obtained a supply of Azacyclonal from America and in his paper on Chemical Tranquillizers he refers to Azacyclonal as “an interesting drug”. Azacyclonal was thought to be the first drug to possess a specific anti-hallucinatory effect.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bettag, , et al., Presented to Meeting of Amer. Psych. Ass., Atlantic City, New Jersey, May, 1955.Google Scholar
Brown, , et al., J. Pharmacol., 1956, 118, 153.Google Scholar
Fabing, , Amer. Pract., 1955, 6, 1678.Google Scholar
Idem and Hawkins, , Dis. nerv. Syst., 1955, 16, 11.Google Scholar
Ferguson, , Antibiotic Med., and Clin. Therapy, 1956, 1, 75.Google Scholar
Gray, and Forrest, , Brit. med. J., 1958, 1, 374.CrossRefGoogle Scholar
Proctor, and Odland, , Dis. nerv. Syst., 1956, 17, 25.Google Scholar
Rinaldi, , et al., Amer. J. Psychiat., 1955, 112, 343.CrossRefGoogle Scholar
Sargant, , Brit. med. J., 1956, 1, 939.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.